This Is What Whales Are Betting On Johnson & Johnson
This Is What Whales Are Betting On Johnson & Johnson
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $150.0 and $175.0 for Johnson & Johnson, spanning the last three months.Deep-pocketed investors have adopted a bullish approach towards Johnson & Johnson (NYSE:JNJ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in JNJ usually suggests something big is about to happen.
有資深投資者對強生（紐交所：JNJ）採取了看好的態度，而市場參與者不應忽視這一點。我們在Benzinga對公共期權記錄的跟蹤揭示了今天這一重要動態。這些投資者的身份仍然未知，但在JNJ中如此大的動作通常暗示着一些重大事件即將發生。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Johnson & Johnson. This level of activity is out of the ordinary.
我們從今天的觀察中得知，Benzinga的期權掃描器突出了強生的11項非凡期權活動。這一活動水平十分不尋常。
The general mood among these heavyweight investors is divided, with 45% leaning bullish and 36% bearish. Among these notable options, 5 are puts, totaling $179,583, and 6 are calls, amounting to $286,331.
這些重量級投資者的整體情緒分歧，45%偏向看好，36%看淡。在這些顯著的期權中，有5個是看跌期權，總計179,583美元，6個是看漲期權，總計286,331美元。
Predicted Price Range
預測價格區間
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $150.0 and $175.0 for Johnson & Johnson, spanning the last three months.
在評估了交易成交量和未平倉合約後，明顯可以看出主要市場操盤手集中關注強生的價格區間在150.0美元到175.0美元之間，持續了三個月的時間。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
In today's trading context, the average open interest for options of Johnson & Johnson stands at 1397.38, with a total volume reaching 2,022.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Johnson & Johnson, situated within the strike price corridor from $150.0 to $175.0, throughout the last 30 days.
在今天的交易背景下，強生的期權的平均未平倉合約爲1397.38，總成交量達到了2,022.00。附帶的圖表描繪了強生在過去30天內，位於150.0美元到175.0美元的行權價區間內，的看漲和看跌期權成交量及未平倉合約的變化。
Johnson & Johnson Call and Put Volume: 30-Day Overview
強生（Johnson & Johnson）看漲、看跌期權成交量：30天總覽
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | TRADE | BEARISH | 12/20/24 | $1.98 | $1.79 | $1.86 | $155.00 | $93.0K | 1.1K | 1.0K |
| JNJ | CALL | SWEEP | BULLISH | 12/20/24 | $4.1 | $3.95 | $4.1 | $150.00 | $57.2K | 527 | 274 |
| JNJ | PUT | SWEEP | BEARISH | 01/17/25 | $2.98 | $2.97 | $2.98 | $150.00 | $44.5K | 5.9K | 168 |
| JNJ | PUT | SWEEP | NEUTRAL | 03/21/25 | $7.45 | $7.4 | $7.4 | $155.00 | $44.4K | 1.5K | 74 |
| JNJ | PUT | SWEEP | BULLISH | 11/22/24 | $19.8 | $19.5 | $19.5 | $172.50 | $39.0K | 0 | 20 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ24C | 看漲 | 交易 | 看淡 | 12/20/24 | $1.98 | $1.79 | $1.86 | $155.00 | $93.0千 | 1.1K | 1.0千 |
| JNJ24C | 看漲 | SWEEP | BULLISH | 12/20/24 | $4.1 | $3.95 | $4.1 | $150.00 | $57.2K | 527 | 274 |
| JNJ24C | 看跌 | SWEEP | 看淡 | 01/17/25 | $2.98 | $2.97 | $2.98 | $150.00 | $44.5K | 5.9K | 168 |
| JNJ24C | 看跌 | SWEEP | 中立 | 03/21/25 | $7.45 | $7.4 | $7.4 | $155.00 | $44.4千美元 | 1.5千 | 74 |
| JNJ24C | 看跌 | SWEEP | BULLISH | 11/22/24 | 19.8美元 | $19.5 | $19.5 | $172.50 | $39.0K | 0 | 20 |
About Johnson & Johnson
關於Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
強生（Johnson & Johnson）是全球最大、最多元化的醫療保健公司，業務包括藥品和醫療設備兩個部門。在2023年的消費業務Kenvue剝離後，這兩個部門現在代表公司的全部銷售額。藥品部門專注於以下治療領域：免疫學、腫瘤學、神經學、肺、心臟病和代謝性疾病。地理上，總收入中略超過一半是在美國產生的。
In light of the recent options history for Johnson & Johnson, it's now appropriate to focus on the company itself. We aim to explore its current performance.
考慮到約翰遜公司最近的期權歷史，現在應該專注於公司本身。我們旨在探討其當前的表現。
Present Market Standing of Johnson & Johnson
強生公司當前市場狀況
- Trading volume stands at 4,081,493, with JNJ's price up by 1.18%, positioned at $153.66.
- RSI indicators show the stock to be may be oversold.
- Earnings announcement expected in 68 days.
- 交易成交量爲4,081,493，JNJ的價格上漲了1.18%，目前爲$153.66。
- RSI指標顯示該股票可能已被超賣。
- 預計還有68天公佈業績。
What Analysts Are Saying About Johnson & Johnson
關於強生的分析師觀點
2 market experts have recently issued ratings for this stock, with a consensus target price of $176.0.
兩位市場專家最近對這隻股票進行了評級，市場共識目標價爲$176.0。
Turn $1000 into $1270 in just 20 days?
在短短20天內，將1000美元變成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* An analyst from Guggenheim has decided to maintain their Neutral rating on Johnson & Johnson, which currently sits at a price target of $162. * An analyst from Wolfe Research downgraded its action to Outperform with a price target of $190.
一位有20年經驗的期權交易員揭示了他的單行圖表技術，顯示何時買入和賣出。複製他的交易，這些交易平均每20天獲利27%。點擊這裏獲取訪問權限。* 古根海姆的一位分析師決定維持對約翰遜公司的中立評級，目前的目標價爲$162。* 沃爾夫研究的一位分析師將其評級下調至表現優於大盤，目標價爲$190。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。
